Analogic Corporation (NASDAQ:ALOG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday.

According to Zacks, “Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems sold primarily to Original Equipment Manufacturers (OEMs). The Company is recognized worldwide for advancing the state of the art in Automatic Explosives Detection, Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), Patient Monitoring, and Advanced Signal Processing. For over 40 years Analogic has created markets by anticipating and solving some of the world’s most complex medical and engineering challenges. Many of the largest, best-known medical imaging companies incorporate our high-performance imaging subsystems into their products. These products are used in most major healthcare facilities around the world to detect and treat disease. They provide extensive design, development, manufacturing, and test capabilities, and offer a unique combination of clinical knowledge and product design experience. “

Separately, Jefferies Group LLC reaffirmed a “hold” rating and issued a $75.00 price target on shares of Analogic Corporation in a report on Wednesday, September 20th. Four equities research analysts have rated the stock with a hold rating, The company currently has a consensus rating of “Hold” and a consensus target price of $85.25.

Shares of Analogic Corporation (NASDAQ:ALOG) traded up $1.30 during mid-day trading on Tuesday, hitting $82.60. The stock had a trading volume of 62,200 shares, compared to its average volume of 96,115. The firm has a market cap of $1,030.00, a PE ratio of 48.39, a PEG ratio of 4.15 and a beta of 0.85. Analogic Corporation has a fifty-two week low of $66.00 and a fifty-two week high of $95.85.

COPYRIGHT VIOLATION WARNING: “Analogic Corporation (ALOG) Downgraded by Zacks Investment Research” was posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/21/analogic-corporation-alog-downgraded-by-zacks-investment-research.html.

Several institutional investors have recently made changes to their positions in the business. Neuberger Berman Group LLC raised its holdings in shares of Analogic Corporation by 9.5% during the third quarter. Neuberger Berman Group LLC now owns 336,517 shares of the medical research company’s stock valued at $28,183,000 after acquiring an additional 29,109 shares during the last quarter. Piedmont Investment Advisors LLC acquired a new position in shares of Analogic Corporation during the third quarter valued at approximately $227,000. Royce & Associates LP raised its holdings in shares of Analogic Corporation by 2.8% during the third quarter. Royce & Associates LP now owns 576,417 shares of the medical research company’s stock valued at $48,275,000 after acquiring an additional 15,469 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Analogic Corporation by 4.1% during the third quarter. Dimensional Fund Advisors LP now owns 947,627 shares of the medical research company’s stock valued at $79,364,000 after acquiring an additional 37,066 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. raised its holdings in shares of Analogic Corporation by 5.4% during the third quarter. Schwab Charles Investment Management Inc. now owns 117,155 shares of the medical research company’s stock valued at $9,812,000 after acquiring an additional 6,029 shares during the last quarter. 96.25% of the stock is owned by institutional investors and hedge funds.

Analogic Corporation Company Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Get a free copy of the Zacks research report on Analogic Corporation (ALOG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.